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Abstract: Alternative lifestyles are likely to be associated with distinct usage of specific medici-
nal products. Our goal was to find out whether the intake of antibiotics during pregnancy and
by children differs according to whether the mothers have alternative or conventional lifestyles.
Therefore, we investigated the use of antibiotics by pregnant women and by children up to 11 years
of age participating in the KOALA Birth Cohort Study. This cohort comprises two recruitment
groups of mother–infant pairs, one with alternative lifestyles (selected via organic food shops, an-
throposophic clinicians and midwives, anthroposophic under-five clinics, Rudolf Steiner schools and
relevant magazines, n = 491) the other with conventional lifestyles (no selection based on lifestyle,
n = 2343). Mothers in the alternative lifestyle group more frequently adhered to specific living
rules and identified themselves with anthroposophy more than mothers in the conventional lifestyle
group. The results revealed significant differences in antibiotic use during pregnancy and in children
from 3 months to 10 years of age between the two groups. The rate of antibiotic use in children
was consistently lower in the alternative lifestyle group than in the conventional lifestyle group.
Antibiotic use in pregnancy was higher in low educated women, and maternal antibiotic use during
lactation was higher after an instrumented delivery in hospital. Antibiotic use in the infant was
higher when they had older sibs or were born in hospital, and lower in those who had been longer
breastfed. After adjustment for these factors, the differences in antibiotic use between the alternative
and conventional groups remained. The results suggest that an alternative lifestyle is associated with
cautious antibiotic use during pregnancy, lactation and in children.
Keywords: restricted antibiotics use; pregnancy; lactation; children; lifestyle; alternative; anthropo-
sophic medicine
1. Introduction
Lifestyles perceived to be distinct from those of the majority of people are often called
“alternative lifestyles”. Such lifestyles are frequently supported by underlying ideologies
and may influence daily practical decisions, such as those concerning school choice for
children, diet composition and use of conventional or complementary medicine therapies
and medications. Whereas medications from complementary medicine are likely to be
frequently used, conventional medications, especially if perceived as problematic, are
expected to be avoided.
Antibiotics are among the most useful but also most problematic medications. Whereas
their use in the treatment of bacterial infections has had a markedly favorable impact on
public health, this success is clouded by the worryingly increasing spread of antibiotic re-
sistance. According to the WHO (see, e.g., [1]), antibiotic resistance is a major public health
problem worldwide, to a large extent caused by the inappropriate and excessive use of
antibiotics. Several studies show that despite recommendations for rational antibiotic use,
Antibiotics 2021, 10, 837. https://doi.org/10.3390/antibiotics10070837 https://www.mdpi.com/journal/antibiotics
Antibiotics 2021, 10, 837 2 of 13
their consumption is still higher than ideal (see [2] for an example). Therefore, measures to
reduce unnecessary use of antibiotics are urgently needed.
Antibiotics are the most frequently used medication among children worldwide [3–7].
Antibiotic use in children may not only contribute to spreading antibiotic resistance but also
affect children’s health. Previous studies have shown that antibiotic exposure early in life
can affect weight development in children [8–10]. Repeated use of antibiotics, particularly
broad-spectrum antibiotics, in children under 24 months of age also seems to be a risk
factor for developing childhood obesity [8]. Moreover, exposure to antibiotics before the
age of 6 months, or repeatedly during childhood, has been associated with increased body
weight in healthy children [9].
The KOALA Birth Cohort Study is a prospective cohort study of mother–infant pairs in
the Netherlands with two distinct recruitment groups: one with conventional lifestyles and the
other with alternative lifestyles [11]. The aim of the present analysis of KOALA data was to
find out whether the intake of antibiotics by children differs according to whether the mothers
have alternative or conventional lifestyles. The results might not only motivate pediatricians to
better consider antibiotic prescriptions for children and how to deal with parents’ expectations
but also alert them to the need for lifestyle-tailored use recommendations.
2. Results
2.1. Demographic, Lifestyle and Health-Related Characteristics
As depicted in Table 1, mothers of the alternative lifestyle group were on average 2 years
older at delivery (33.7 vs. 31.7 years) and more often had a higher education (72.7% vs. 42.5%).
There were several indications that women in the alternative lifestyle group had
lifestyles that differed from the conventional one. First, they more often adhered to certain
living rules (e.g., those concerning vegetarianism (16.9% vs. 1.5%) and anthroposophy
(14.3% vs. 0.1%)) than the women in the conventional lifestyle group. Secondly, they more
often actively chose to consume organic food (87.3% vs. 20.8%) and biodynamic products
(73.2% vs. 7.2%).




















132/491 27.0% 256/2340 11.1%
HBO
Higher vocational education
225/491 46.0% 728/2340 31.5%
MBO
Vocational secondary education
52/491 10.6% 706/2340 30.6%
VWO—high school
Pre-university education












8/491 1.6% 123/2340 5.3%
Elementary school 2/491 0.4% 3/2340 0.1%
Other 11/491 2.3% 97/2340 4.2%
Missing values 2/491 0.4% 34/2340 1.5%







Adhered to living rules during the last month 156/491 32.6% 51/2340 2.2%
Adhered to . . .
. . . Vegetarianism 83/491 16.9% 36/2343 1.5%
. . . Veganism 1/491 0.2% 1/2343 0.0%
. . . Macrobiotics 6/491 1.2% 1/2343 0.0%
. . . Anthroposophic lifestyle 70/491 14.3% 3/2343 0.1%
. . . Life reform movement 19/491 3.9% 4/2343 0.2%
. . . Islam 0/491 0.0% 10/2343 0.4%
. . . Buddhism 3/491 0.6% 0/2343 0.0%
. . . Judaism 3/491 0.6% 0/2343 0.0%
. . . Hinduism 0/491 0.0% 1/2343 0.0%
. . . Other 31/491 6.3% 6/2343 0.3%
Intentional choice of some organic products
Consumed organic products 428/490 87.3% 485/2333 20.8%
Did not consume organic products 52/490 10.6% 1471/2333 63.1%
Did not know/did not care 10/428 2.0% 377/2333 16.2%
Intentional choice of biodynamic products
Consumed biodynamic products 357/488 73.2% 167/2327 7.2%
Did not consume biodynamic products 131/488 26.8% 2120/2327 92.8%
From the beginning of the pregnancy until week 34, a higher percentage of women
in the alternative group reported genital Candida infections (22.7% vs. 14.1%) and oral
aphthae (12.9% vs. 8.0%) than the conventional group. After the third month of pregnancy,
a higher percentage of women in the conventional lifestyle group reported diarrhea and
urinary infections (see Table 2). Similar frequencies between the two recruitment groups
were found concerning the frequency of Candida infections in the mouth (during the
pregnancy), as well as fever and flu (after the third month of pregnancy).
Pregnancy duration was similar in the two groups (39.6 vs. 39.5 weeks), whereas
neonates in the alternative group were on average slightly though statistically significantly
heavier at birth than those of the conventional group (3582 vs. 3487 g).















Candida infection in the mouth during
the pregnancy
6/490 1.2% 13/2339 0.6% 0.095
Candida infection in the genital area
during the pregnancy
111/488 22.7% 330/2340 14.1% <0.001
Aphthae during the pregnancy 63/489 12.9% 186/2338 8.0% 0.001
Lip cold sores during the pregnancy 58/487 11.9% 287/2338 12.3% 0.446
Common cold after third month 315/490 64.3% 1502/2339 64.2% 0.510
Fever after third month 46/490 9.4% 222/2338 9.5% 0.510
Flu after third month 52/491 10.6% 252/2337 10.8% 0.488
Diarrhea after third month 97/490 19.8% 551/2334 23.6% 0.037
Urinary tract infections after third month 28/489 5.7% 187/2338 8.0% 0.048
Duration of pregnancy (weeks) 480 39.6 ± 1.4 2332 39.5 ± 1.5 0.128
Birth weight (g) 482 3582 ± 506 2330 3487 ± 512 <0.001
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2.2. Antibiotic Use
As shown in Figure 1, several significant differences between the two groups were
found for antibiotics use by pregnant women and by children during the first 12 months of
life. During pregnancy, 9.4% (46/489) of the participants in the alternative lifestyle group
and 13.7% (321/2337) of the participants in the conventional lifestyle group used antibiotics
(p = 0.026). In the last month of pregnancy, the antibiotics use was lower (2.9% vs. 4.4%)
and the difference between the two groups was not statistically significant (p = 0.144). After
delivery, a significant difference was found between both groups in the use of penicillin
or other antibiotics during breastfeeding (p = 0.003): within the alternative group, 9.8%
(44/447) of the breastfeeding women used antibiotics; in the conventional group, 15.5%
(252/1631) did so.
 
Figure 1. Antibiotic use by mothers during pregnancy and breastfeeding (when infants were
3 months old). Data on antibiotic use during pregnancy and in the last month of pregnancy were
available for 2650 women (476 in the alternative lifestyle group and 2174 in the conventional lifestyle
recruitment group) and during breastfeeding data were available for 2654 women (477 and 2177).
Given the distinct maternal demographic and lifestyle characteristics in the alternative
and conventional lifestyle groups (see Table 1), we set out to evaluate whether some of
these characteristics could at least in part explain the differences in antibiotics consumption
during pregnancy and lactation (see Table 3). During pregnancy, the difference between
use of antibiotics in the two groups remained statistically significant even when maternal
education and organic food choice were included. This was found to be true even though
maternal education per se was associated with more frequent antibiotic use (OR, 1.53;
95% CI, 1.13–2.09). The difference between antibiotic use during lactation in the two groups
remained statistically significant even when maternal education was included in the logistic
regression model. Finally, it remained significant when including delivery mode (artificial
vs. vaginal at home) and the number of older siblings. Maternal education per se was not
associated with different antibiotic use during lactation.
From the age of 3 months to 2 years, antibiotic use increased in both groups (see
Figure 2). Furthermore, the differences in antibiotic use between the alternative and the
conventional groups also increased with age. Within the alternative group, statistically
significantly fewer antibiotics were used than in the conventional group at all time-points
except in the case of penicillin at 3 months of age (p = 0.052). The difference in antibiotic
use between the conventional and alternative groups was relatively small between 3 and
7 months of age (1.3%; 2.5%; 3.1%), but it increased over time from 7 months to 2 years of
age (5.6%; 4.5%; 7.7%; 6.9%; see Figure 2).
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Conventional group 321 (13.8%) 2327 252 (15.5%) 1629
Alternative group 46 (9.4%) 488 44 (9.8%) 447
Univariable model OR (95% CI) OR (95% CI)
Conventional group 1.0 (reference) 1.0 (reference)
Alternative group 0.65 (0.47–0.90) 0.60 (0.42–0.84)
Multivariable models
Conventional group 1.0 (reference) 1.0 (reference)
Alternative group 0.67 (0.48–0.94) 0.63 (0.44–0.90)
High education 1.0 (reference) 1.0 (reference)
Mid-level education 1.13 (0.88–1.45) 0.81 (0.61–1.08)
Low education 1.59 (1.17–2.18) 0.98 (0.66–1.45)
Home delivery - 1.0 (reference)
Natural hospital birth - 1.12 (0.84–1.50)
Instrumental hospital * - 1.43 (1.02–2.00)
No older siblings - 1.0 (reference)
One or more siblings - 0.91 (0.61–1.21)
Breastfeeding <1 month - 1.0 (reference)
Breastfeeding 1 month - 1.22 (0.70–2.11)
Breastfeeding 2 months - 1.00 (0.60–1.66)
Breastfeeding 3 months - 0.95 (0.60–1.49)
Maternal age (per year) 1.03 (0.99–1.06) 0.99 (0.96–1.03)
* instrumentally assisted delivery and cesarean section. Results from logistic regression with the maternal antibiotic use (AB) as the
outcome variable (yes/no). The analysis of AB use during lactation was confined to mothers who had initiated breastfeeding; numbers
of subjects may further differ slightly from the baseline table due to a few missing values in covariables. Odds ratios (ORs) with 95%
confidence intervals (95% CIs) were used in the logistic regression analysis, with antibiotic use as the outcome variable and a univariable
model with only the alternative vs. conventional groups and with the indicated multivariable adjustment. Statistically significant results
(p < 0.05) are printed bold.
We reasoned that demographic and lifestyle characteristics of the mother could also
be associated with antibiotic treatments in the case of small children. Antibiotic use by
children was lower in the alternative than the conventional group in all periods covered
by the questionnaires (see Table 4). In the univariable regression, this manifested as lower
ORs with 95% CIs that excluded 1.0 (see Table 4), with the strongest association in the first
year (ORs about 0.5). When adjusted in multivariable models, the association attenuated
somewhat (to 0.6), but the 95% CIs still excluded 1.0, indicating that the other factors only
partially explained the difference in antibiotic use between the alternative and conventional
lifestyle groups. Maternal education and age were unrelated to antibiotic use. Risk factors
for antibiotic use in the first year were hospital delivery (vs. home delivery, which had the
strongest association for antibiotic use in the 8–12 month period) and having one or more
older siblings; while breastfeeding duration showed a protective association (see Table 4).
For antibiotic use in the second year, all these factors had no impact any more, while the
difference between the alternative and conventional groups was retained, albeit in a less
pronounced manner than in the first year (OR: 0.72). Anthroposophic orientation and use
of organic foods were unrelated to children’s antibiotic use in multivariate models and did
not change the difference between the alternative and conventional groups, and they were
omitted from the final models.
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Figure 2. Antibiotic use in infants/children from 3 months to 2 years of age. Data on penicillin at
3 months of age were available for 2634 children (473 in the alternative lifestyle group and 2161 in the
conventional lifestyle recruitment group); data on other antibiotics at 3 months of age were available
for 2650 children (476 and 2174, respectively); data on penicillin at 7 months of age were available
for 2588 children (471 and 2117); data on other antibiotics at 7 months of age were available for
2587 children (471 and 2116); data on penicillin at 12 months of age were available for 2549 children
(467 and 2082); data on other antibiotics at 12 months of age were available for 2534 children (464
and 2070); data on penicillin at 2 years of age were available for 2461 children (435 and 2026); and
data on other antibiotics at 2 years of age were available for 2512 children (448 and 2064).
In this section we report the results from the logistic regression with the child’s antibi-
otic use (AB) as the outcome variable (yes/no) in the periods covered by the questionnaires.
The numbers of subjects may differ slightly from the baseline table due to a few missing
values in covariables. ORs with 95% CI were used. Statistically significant results are
printed bold. Breastfeeding was included as a continuous variable in months up to the end
of the age period, e.g., for age periods 4–7 breastfeeding ranged from 0 (never breastfed) to
7 months (breastfeeding up to and including the 7th month). The ORs were multiplicative;
for instance, the OR of 0.92 per month of breastfeeding translates to 0.92ˆ3 = 0.78 for a
contrast between 3 and 0 months. The same is true for a contrast between 7 and 3 months
of breastfeeding, which would agree with about a 20% lower risk of antibiotic use, and
0.92ˆ7 = 0.56 for a contrast between 7 and 0 months of breastfeeding, agreeing with about a
40% lower risk of antibiotic use (the logistic regression model assumes the linearity of the
natural log of the odds).
From the age of 6 to 11 years, the number of antibiotic treatments decreased with age
in both lifestyle groups, even though, within the alternative group, a slight increase in
antibiotic use could be observed for the ages of 8–11 years (see Figure 3). Fewer children
in the alternative lifestyle group than in the conventional group underwent antibiotic
treatments. In most cases, the difference in antibiotic treatment between the two groups
proved to be significant. This difference was relatively large at the age of 6–7 years and
decreased as the children got older (8.6%; 5.2%; 4.9%; 0.8%).
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Conventional group 169 (7.8%) 2161 397 (18.8%) 2117 548 (26.3%) 2085 519 (25.9%) 2003
Alternative group 20 (4.2%) 473 49 (10.4%) 472 71 (15.2%) 467 86 (19.6%) 439
Univariable model OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Conventional group 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference)
Alternative group 0.52 (0.32–0.84) 0.50 (0.37–0.69) 0.50 (0.38–0.66) 0.70 (0.54–0.90)
Multivariable models
Conventional group 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference)
Alternative group 0.60 (0.36–0.99) 0.63 (0.45–0.88) 0.59 (0.44–0.79) 0.72 (0.54–0.95)
High education 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference)
Mid-level education 0.99 (0.70–1.40) 0.84 (0.66–1.06) 0.88 (0.71–1.08) 1.05 (0.85–1.29)
Low education 1.31 (0.86–2.02) 0.90 (0.66–1.24) 0.92 (0.69–1.23) 1.04 (0.78–1.39)
Home delivery 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference)
Natural hospital birth 1.40 (0.99–1.97) 1.13 (0.89–1.43) 1.34 (1.08–1.66) 1.16 (0.94–1.43)
Instrumental hospital 1.44 (0.94–2.19) 1.14 (0.85–1.53) 1.62 (1.25–2.09) 1.08 (0.83–1.41)
No older siblings 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference)
One or more siblings 1.57 (1.11–2.23) 1.45 (1.14–1.83) 1.33 (1.07–1.64) 0.90 (0.73–1.10)
Breastfeeding (per month) 0.92 (0.84–1.02) 0.92 (0.88–0.95) 0.95 (0.93–0.98) 0.99 (0.97–1.02)
Maternal age (per year) 0.98 (0.94–1.02) 0.98 (0.95–1.01) 1.01 (0.98–1.04) 1.01 (0.99–1.04)
 
Figure 3. Antibiotic treatment of 6 to 11 year old children (in each case, most recent year). Data on
antibiotics use at 6–7 years of age were available for 1964 children (362 in the alternative lifestyle
group and 1602 in the conventional lifestyle recruitment group); at 7–9 years data were available
for 1881 children (350 and 1531); at 8–10 years of age data were available for 1821 children (340 and
1481); and at 10–11 years of age data were available for 1634 children (314 and 1320).
Figure 4 shows that, in the two lifestyle groups, the majority of the children had no
antibiotics treatments (i.e., 0 = zero antibiotic treatments per person-year), but it also reveals
several differences between the two lifestyle groups. Firstly, the percentage of children
with 0 antibiotic treatments per person-year was higher in the alternative group than in the
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conventional group. In addition, the percentages of children with between 1–2 antibiotic
treatments and 2–3 antibiotic treatments per year were lower in the alternative lifestyle
group than they were in the conventional lifestyle group.
Figure 4. Number of antibiotic treatments given to a child per person-year. The number of antibiotic
treatments per person-year was calculated by dividing the sum of all antibiotic treatments by
observation time. From 3 months to 12 months, information was available on use or non-use
of antibiotics; if the parents reported any antibiotic treatment, 1 antibiotic course was assumed.
Thereafter, the number of antibiotic courses (1, 2, 3 or more antibiotic courses) was asked for directly.
The time consisted of the number of months addressed in the successive questionnaires (from data
from previous questionnaire to that of the current questionnaire). In this way, it was possible to
control for differences in the timing of filling in the various questionnaires.
3. Discussion
Taken together, our data show that pregnant and breastfeeding women, as well as
children, in the alternative lifestyle group generally used antibiotics less often than in the
conventional lifestyle group. Interestingly, the differences between the two groups with
regard to maternal antibiotic use were significant during pregnancy and breastfeeding
and continued in their offspring from the beginning, increasing up to age 6–7. Thereafter,
the difference was attenuated. Use of penicillin followed the pattern of the remaining
antibiotics, except at age two, when use of penicillin was similar in both lifestyle groups.
Among the children, the number of antibiotic treatments per person-year was lower in the
alternative group than in the conventional group.
The KOALA Birth Cohort Study is being carried out in the Netherlands, a country
with one of the lowest frequencies of antibiotics consumption worldwide [12]. According to
OECD data, average antibiotic consumption in the Netherlands was about 12 defined daily
doses per day (DDD) per 1000 inhabitants in 2014, which was approximately half of the
average OECD consumption; no increase was observed between 2005 and 2014 [12]. The
fact that lifestyle influences antibiotics consumption suggests that even in the Netherlands
a considerable portion of the prescriptions are not really needed. This is in line with results
showing that in the Netherlands approximately 50% of antibiotic prescriptions for bronchi-
tis, tonsillitis and sinusitis were not issued in accordance with guidelines [13]. It appears
conceivable that, in countries with higher consumption, stronger effects from lifestyle can
be expected. Interestingly, the lower consumption of antibiotics was already apparent
during pregnancy (30% fewer antibiotic treatments in the alternative lifestyle group), a
period in which decisions have to be particularly carefully considered, as infections may
negatively affect the course of pregnancy, as well as mothers’ and children’s health [14], at
the same time that any unnecessary treatment should be avoided. The lower consumption
of antibiotics during pregnancy in the alternative lifestyle group relative to the conventional
group could in part be associated with the lower prevalence of urinary infections in that
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group. The similar (or even higher) frequency of the remaining infectious diseases and
fever in the alternative group speaks against such associations however. Finally, the obstet-
ric outcomes, duration of pregnancy and birth weight were comparable between the two
groups, suggesting that the (30%) lower antibiotic use did not have negative consequences.
The main limitation of the present analysis was the lack of information on children’s
health outcomes and complications/hospitalizations. Moreover, it would also have been
interesting to add information on how physicians who were consulted by participants
in the two recruitment groups worked; for instance, how much time they invested in
patient care, how many patients they saw per day and how much communication with the
parents/caregivers occurred per infectious syndrome.
The higher educational level of the alternative group mothers could have contributed
to the lower antibiotic use for themselves and among their children. A Danish cohort study
showed that the prevalence of antibiotic use was higher among mothers with a lower level
of education [15]. Similarly, a survey on parental knowledge, attitudes and practice of
antibiotic treatment in children found that low parental education was the most important
independent risk factor positively related to antibiotic use [16]. Our results confirm that
lower education is associated with higher antibiotic use during pregnancy (but not during
lactation). Differences in maternal education (which can also be taken as an income
indicator) did not, however, explain the observed differences between antibiotic treatment
during pregnancy—nor during lactation—in the alternative and conventional lifestyle
groups. Differences in antibiotic use during lactation between the two lifestyle groups
were due neither to distinct maternal education levels nor to delivery mode (artificial vs.
vaginal at home) or number of older siblings (as an indicator for maternal experience).
With regard to early childhood and in line with previous studies [17], our results
corroborated that breastfeeding protects against infections in the first year of life. Moreover,
they revealed more frequent antibiotic treatments in children delivered in hospital (relative
to home deliveries that are usual in the Netherlands), which may be related to medicaliza-
tion (e.g., parents being more inclined to seek medical care), but perhaps also to a higher
risk of breastfeeding problems (especially after cesarean operations). Older siblings were
included as an indicator of maternal experience with child care (expected to lead to, e.g.,
more non-antibiotic home medication for a feverish child) but the results indicated a higher
antibiotic use (likely due to older siblings being a source of infections). Finally, the alterna-
tive lifestyle group included a considerable proportion of families with an anthroposophic
orientation and users of organic foods (Table 1). Adherence to anthroposophy is likely to
be associated with–but not conditio sine qua non for–the use of anthroposophic medicine.
This type of medicine (see below) advocates prudent use of childhood vaccination and
antibiotic use to favor the development of natural immunity to infections in children [18].
However, the association between adherence to anthroposophy and antibiotic use was
weak in our study. Also, organic food consumption during pregnancy (as indicator of
investment in prudent or nature-oriented lifestyles) was not associated with antibiotic use.
Neither adherence to anthroposophy not organic food consumption explained the lower
use in the alternative group. Other lifestyle characteristics that strongly influence antibiotic
use—be it during pregnancy, lactation or early childhood—deserve further investigations.
Given that the decision for or against an antibiotic treatment should be taken exclu-
sively by physicians, influences of parental lifestyle are at first sight surprising. However,
patient expectations appear to be a strong predictor of general practitioners’ prescribing
behavior [19] and patients’ expectations and physicians’ assumptions regarding these expec-
tations are—next to diagnostic uncertainty—important factors leading to over-prescription
of antibiotics [20–22]. This suggests that physicians have to be trained not only to prescribe
fewer antibiotics, but also to communicate the disadvantages of unnecessary use of antibi-
otics to lay people, namely to their patients and, in the case of child patients, their parents.
Especially in situations in which parents are anxious, as frequently happens when children
have a fever and specific symptoms, is it important that physicians are able to deliver
consistent and reliable information [21]. In addition, simple measures, such as introducing
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an illness-focused interactive booklet, might have positive effects [23]. Since the knowledge
and attitude of patients concerning antibiotics can possibly influence physicians’ expecta-
tions [19], their improvement should also be a goal of public health measures. It should be
kept in mind that interventions aimed at reducing the intentions to use antibiotics among
of in child-bearing age may contribute to slowing down the development of antibiotic
resistance and reducing the negative side effects of antibiotics in children.
In principle, the higher adherence to life rules—related to religious or philosophi-
cal backgrounds—in the alternative lifestyle group might have contributed to the lower
antibiotics use in this group. This might have happened directly if their rules included
restrictions on antibiotics, but also indirectly if the rules strengthened the community and
the parents who belonged to this community had specific expectations from therapies
other than antibiotics. In the alternative lifestyle group, the number of participants who
reported adhering to an anthroposophic lifestyle was higher than in the conventional
lifestyle group and the large majority of the participants mentioned choosing products
from—anthroposophy-inspired—biodynamic production. Therefore, and also due to the
means of recruitment (in part via anthroposophic general practitioners and midwifes,
anthroposophic under-five clinics and Rudolf Steiner schools), it is likely that more women
and children in the alternative lifestyle group were being treated by physicians with a
training in anthroposophic medicine. This type of integrative medicine [24,25] promotes
a restricted use of antibiotics at the same time that supportive treatments are developed
and actively used. Especially in respiratory and ear infections—two very frequent indi-
cations for antibiotic use in children—anthroposophic physicians tend to prescribe fewer
antibiotics [26]. In both types of infections, there is a broad discussion on the advantages
of watchful waiting (see [27] and [28], respectively). At least in the case of some types
of otitis media, a multimodal approach that includes several non-invasive supportive
therapies (pneumatization exercises, education, an antiallergenic diet, nasal hygiene, useful
constitutional therapy and thermal interventions; e.g., P.E.A.N.U.T.) appears to contribute
to the success of waiting [29]. The fact that physicians with training in anthroposophic
medicine hold longer consultations than is usual in conventional medicine (see [30]) could
also contribute to taking the risk of not prescribing antibiotics right away. Finally, it is con-
ceivable that further therapies from complementary medicine may contribute to reducing
unnecessary antibiotics consumption [31].
To achieve a global reduction of antibiotics use, it is necessary to know how to tailor
the required scientific information and the corresponding recommendations to various
countries and even regions [32]. By emphasizing the importance of co-existing parental
lifestyles in the use of antibiotics during pregnancy and during the first years of their
offspring’s lives, our work adds to the ongoing discussion. Information and recommenda-
tions should also take aspects of lifestyle into consideration. A more detailed—possibly
qualitative—investigation of the reasons behind the restrictive use of antibiotics associated
with alternative lifestyles might unveil new possibilities for improving motivation in the
general population.
4. Materials and Methods
4.1. Study Population
The KOALA Birth Cohort Study is an ongoing cohort study in the Netherlands of
factors influencing atopic disease, with a main focus on lifestyle [18]. The study was
approved by the Medical Ethics Committee of Maastricht University Medical Centre, the
Netherlands, and written informed consent was given by the parents of the participat-
ing children. From October 2000 to December 2002, a total of 3030 pregnant women
were recruited at 34 weeks of pregnancy. Pregnant women with a conventional lifestyle
(n = 2343) were recruited from an ongoing prospective cohort study on pregnancy-related
pelvic pain in the Netherlands [18]. The other group of pregnant women (n = 491) were
recruited through alternative lifestyle-related channels, such as organic food shops, anthro-
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posophic general practitioners and midwives, anthroposophic under-five clinics, Rudolf
Steiner schools and relevant magazines [18].
4.2. Data on Antibiotic Use
Information on antibiotic use was collected by repeated parent questionnaires from
34 weeks of pregnancy to 11 years of age, in which different types of questions on antibiotic
use were asked. Whether or not the mother used antibiotics during pregnancy or while
breastfeeding and whether the infant was given antibiotics until 3 months of age was
analyzed as a categorical variable (“no”, “yes”, “don’t know”). From 3 months of age to
1 year of age, whether or not the child was given penicillin or other antibiotics and for how
long were analyzed using categorical variables (“no”, “yes 1–3 days”, “yes 4–10 days”,
“yes more than 10 days”). These variables were chosen to split the group into “no” and
“yes” groups, where the category “yes” contained the three response options (1–3 days,
4–10 days and more than 10 days). At the age of 2 years, the use of penicillin or other antibi-
otic treatment during the child’s second year of life, as well as how often this occurred, was
surveyed by means of categorical variables (“never”, “once”, “twice”, “more than twice”,
“don’t know”). The number of antibiotic courses prescribed to children from the age of 6 to
11 years was also analyzed as a categorical variable (“never”, “once”, “twice”, “three times
or more”). From 3 months of age on, the initial text of the questions on antibiotics treatment
was “How often did your child (have) one of the following medications in . . . [observa-
tional time]?”; thereafter, a distinction was made between treatment with penicillin and
treatment with other antibiotics. The text on penicillin-only treatments was: “Penicillin for
strep throat or skin infection (syrup/drink, such as: Broxil [the acid-stable penicillin deriva-
tive pheneticillin], Acipen-V [phenoxymethylpenicillin], Phenoxymethyl-penicillin)”; the
text on other antibiotics was: “Antibiotic treatment for other infections or inflammations
such as ear infection, bladder infection etc. (drops/suspension, such as Clamoxyl [amoxi-
cillin], Amoxi Disp [amoxicillin dispersible tablets], Amoxicillin, Flemoxin [amoxicillin],
Zithromax [azithromycin], Doxycyline, Co-trimoxazole [trimethoprim/sulfamethoxazole],
Bactrimel [trimethoprim], Eusaprim [trimethoprim/sulfamethoxazole], Trimethoprim,
Monotrim [trimethoprim], Sulphamethizole, Sulphafurazole, Sulfadiazine)”.
4.3. Statistical Analysis
Descriptive data on the alternative and conventional groups were analyzed using
descriptive statistics with the IBM SPSS Statistics 25 statistical software; the results were
presented as numbers and percentages. The baseline measurement was available for
2834 respondents in total, of whom 2343 were from the conventional lifestyle recruitment
group and 491 from the alternative lifestyle recruitment group. Numbers and percentages
of the two groups were compared by categorical variables on the use of antibiotics during
pregnancy, breastfeeding and oral treatment of the child. In total, 18 outcome variables
related to antibiotic use were analyzed. Furthermore, several demographic, lifestyle and
health-related characteristics of the alternative and conventional recruitment groups were
analyzed as independent determinants.
Differences between both recruitment groups were evaluated by Chi-square test and
analysis of variance for continuous and categorical variables, respectively. Statistical
significance was set at p < 0.05. Logistic regression was used to estimate the OR for
antibiotic use, comparing the alternative and conventional lifestyle groups, without and
with adjustment for the possible confounders. The KOALA cohort study has a long follow-
up period and not all respondents participated in the study for the same amount of time.
To take this into account, person-years were used to calculate the number of antibiotic
treatments given to the respondents. For the period from 3 months to 12 months, one
antibiotic treatment was assumed; for children aged 2 years to 11 years, the number of
antibiotic treatments (1, 2 or 3 or more antibiotic treatments) was available. The time
period corresponding to the antibiotic intake consisted of the number of months until the
questionnaire on the child’s antibiotic use had been returned.
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